According to a recently published report, the global ophthalmic devices market is expected to grow at the CAGR of 6.5% during 2015-2022 and it estimated to be $34.7billion by 2022. The global ophthalmic devices market is segmented on the basis of solutions type, by service type, by data center type and geography. The report on Global Ophthalmic Devices Market forecast 2015-2022 provides detailed overview and predictive analysis of the market.
The Global Ophthalmic Devices Market is expected to grow exponentially due to rise in incidence of various ocular disorders, &technological advancement. Rise in geriatric population and rising demand for improved diagnostic and surgical technologies are creating huge scope for the market. Additionally, rising in healthcare expenditure, increasing eye disorders leading to blindness and visual impairment is expected to create opportunity for the global ophthalmic devices market. Active lifestyle has increased the number of patients undergoing surgery which acts as an opportunity for Global Ophthalmic Devices.
Full report available Global Ophthalmic Devices Market Forecast 2015-2022 report at http://www.briskinsights.com/report/ophthalmic-devices-market
Global ophthalmic devices market is expected to contribute highest in North America followed by Europe. Rise in adoption of global ophthalmic devices by surgical devices such as cataract surgical devices, glaucoma surgery devices, refractive surgery devices and vitreoretinal surgery devices are major drivers for the global ophthalmic devices market. Alcon Inc., Abbott Medical Optics Inc., Bausch & Lomb Inc., Essilor International S.A., Carl Zeiss Meditec AG, Johnson & Johnson, Haag Streit AG, Nidek Co. Ltd. are the key market players. Mergers and acquisition, partnerships are the key winning strategy of the market.
Release ID: 977